Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Karyopharm Therapeutics Inc. (KPTI)

16.34   0.96 (6.24%) 02-28 16:00
Open: 14.81 Pre. Close: 15.38
High: 16.38 Low: 14.6
Volume: 1,736,269 Market Cap: 1071M
Karyopharm Therapeutics Inc. is a clinical-stage pharmaceutical company. It focuses on the discovery, development, and commercialization of first-in-class drugs directed against nuclear transport and related targets to treat cancer and other diseases.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 16.408 - 16.486 16.486 - 16.557
Low: 14.422 - 14.506 14.506 - 14.582
Close: 16.188 - 16.34 16.34 - 16.477

Technical analysis

as of: 2020-02-28 4:30:07 PM
Stoxline posted a STRONG BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 21.44     One year: 25.05
Support: Support1: 15.29    Support2: 13.39
Resistance: Resistance1: 18.36    Resistance2: 21.44
Pivot: 16.07
Moving Average: MA(5): 15.08     MA(20): 16.34
MA(100): 15.66     MA(250): 10.46
MACD: MACD(12,26): -0.52     Signal(9): -0.47
Stochastic oscillator: %K(14,3): 40.84     %D(3): 26.21
RSI: RSI(14): 50.03
52-week: High: 20.09  Low: 4.00  Change(%): 263.9
Average Vol(K): 3-Month: 119828  10-Days: 133195

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
KPTI has closed below upper band by 43.1%. Bollinger Bands are 24.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Karyopharm Enters Distribution Agreement for XPOVIO in Israel
Karyopharm and Promedico entered into a distribution agreement for the commercialization of XPOVIO in Israel and the Palestinian Authority. The post Karyopharm Enters Distribution Agreement for XPOVIO in Israel appeared first on Investing News Network .

The Daily Biotech Pulse: Positive Data Readouts To Spur Aclaris, Moderna And Ultragenyx
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 9) Acceleron Pharma Inc (NASDAQ: XLRN ) Allergan plc (NYSE: AGN ) Applied Genetic Technologies Corp (NASDAQ: AGTC ) ( announced positive midstage results for its gene therapy to treat inherited eye disorder) Applied Therapeutics Inc (NASDAQ: APLT ) Bio-Rad Laboratories, Inc. (NYSE: BIO ) Bristol-Myers Squibb Co (NYSE: BMY ) Collegium Pharmaceutical Inc (NASDAQ: COLL ) COLLPLANT BIOTE/S ADR (NASDAQ: CLGN ) DBV TECHNOLOGIE/S ADR (NASDAQ: DBVT ) (reported positive results for a late-stage study of its peanut allergy patch) DexCom, Inc. (NASDAQ: DXCM ) Global Blood Therapeutics Inc (NASDAQ: GBT ) Grifols SA - ADR ADR Class B (NASDAQ: GRFS ) Inspire Medical Systems Inc (NYSE: INSP ) ITAMAR MED LTD/S ADR (NASDAQ: ITMR ) Karyopharm Therapeutics Inc (NASDAQ: KPTI ) LeMaitre Vascular Inc (NASDAQ: LMAT ) Masimo Corporation (NASDAQ: MASI ) Medtronic PLC (NYSE: MDT )(announced the acquisition of Stimgenics) Molecular Templates Inc (NASDAQ: MTEM ) Morphosys Ag (NASDAQ: MOR ) NuVasive, Inc.

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 62.79
Shares Float (M) 34.71
% Held by Insiders 17.97
% Held by Institutions 97.31
Shares Short (K) 9570
Shares Short P. Month (K)

Stock Financials

EPS -3.420
Book Value (p.s.) 0.950
PEG Ratio 0.24
Profit Margin
Operating Margin -884.51
Return on Assets (ttm) -49.1
Return on Equity (ttm) -181.1
Qtrly Rev. Growth 5401.7
Gross Profit (p.s.) -2.087
Sales Per Share
EBITDA (p.s.) -3.226
Qtrly Earnings Growth
Operating Cash Flow (M) -199.50
Levered Free Cash Flow (M) -124.92

Stock Valuations

P/E -4.78
P/E Growth Ratio 0.06
P/BV 17.20
P/S 43.00
P/CF -5.14

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.